Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system

Pharmacology and Toxicology

Volumn 86, Issue 5, 2000, Pages 234-241

  Somani, Satu M ^a   Husain, Kazim ^a   Whitworth, Craig ^a   Trammell, Gary L ^b   Malafa, Mokenge ^a   Rybak, Leonard P ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT SPRINGFIELD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; CISPLATIN; CREATININE; DRUG VEHICLE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0034112713     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-41.x     Document Type: Article

References (60)

1. Aebi, H.: Catalase in vitro. Meth. Enzymol. 1984, 105, 121-126.
2. Babu, E., V. K. Gopal Krishnan, I. N. P. Sriganth, R. Gopal Krishnan & D. Sakthisekaran: Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol. Cell. Biochem. 1995, 144, 7-11.
3. Ban, M., D. Hettich & N. Huguet: Nephrotoxicity mechanism of cis-platinum (II) diamine dichloride in mice. Toxicol. Lett. 1994, 71, 161-168.
4. Basinger, M. A., M. M. Jones & M.A. Holscher: L-methionine antagonism of cisplatinum-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 1990, 103, 1-15.
5. Biewenga, G. P., G. R. R. Haenen & A. Bast: The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 1997, 29, 315-331.
6. Bodenner, D. L., P. C. Dedon, P. C. Keng, J. C. Katz & R. F. Borch: Selective protection against cisplatin induced toxicity in kidney, gut, and bone marrow by DDTC. Cancer Res. 1986, 46, 2751-2755.
7. Boogaard, P. J., E. L. Lempers, G. J. Mulder & J. H. N. Meerman: 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumour activity. Biochem. Pharmacol. 1991, 41, 1997-2003.
8. Busse, E., G. Zimmer, B. Schopoh & K. B. Ornhuber: Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung. 1992, 42, 829-831.
9. Carlberg, I. & B. Mannervik: Glutathione reductase. Meth. Enzymol. 1995, 113, 484-490.
10. Cozzaglio, L., R. Doci, G. Colla, F. Zunino, G. Casciarri & L. Gennari: A feasibility study of high-dose cisplatin and 5-fluorouracil with glutathione protection in the treatment of advanced colorectal cancer. Tumori 1990, 76, 590-594.
11. DeWoskin, R. S. & J. E. Riviere: Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicol. Appl. Pharmacol. 1992, 112, 182-189.
12. Di Re, F., S. Bohm, S. Oriana, G. B. Spatti & F. Zunino: Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer. Can. Chemother. Pharmacol. 1990, 25, 355-360.
13. Dobyan, D. C., J. M. Bull, F. R. Strebel, B. A. Sunderland & R. E. Bulger: Protective effects of O-beta-hydroxyethyl-rutoside on cisplatin-induced acute renal failure in the rat. Lab. Invest. 1986, 55, 557-563.
14. Esposito, M., R. A. Fulco, P. Collecchi, A. Zicca, A. Cadoni, F. Merlo, R. Rosso & A. Sobero: Improved therapeutic index of cisplatin by procaine hydrochloride. J. Natl. Cancer Int. 1990, 82, 677-684.
15. Esposito, M., M. Viale, M. O. Vannozzi, A. Zicca, A. Cadoni, F. Merlo & L. Gogioso: Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II). Toxicol. Appl Pharmacol. 1996, 140, 370-377.
16. Flohe, L. & W. Gunzler: Assays of glutathione peroxidase. Meth. Enzymol. 1994, 105, 114-121.
17. Fontanelli, R., G. Spatti, F. Raspagliesi, F. Zunino & F. Di Re: A preoperative single course of high dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann. Oncol. 1992, 3, 117-121.
18. Gandara, D. R., E. A. Perez, V. Weibe & M. W. DeGregorio: Cisplatin chemoprotection and rescue: Pharmacologic modulation of toxicity. Semin. Oncol. 1991, 18, 49-55.
19. Greenamyre, J. T., O. M. Garcia & J. G. Greene: The endogenous cofactors, thioctic acid and dihydrolipoic acid are neuroprotective against NMDA and malonic acid lesions of striatum. Neurosi. Lett. 1994, 171, 17-20.
20. Hamers, F. P. T., J. H. Brakkee, E. Cavalletti, M. Tedeschi, L. Marmonti, G. Pezzoni, J. P. Neijt & W. H. Gispen: Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res. 1993, 53, 544-549.
21. Handelman, G. J., D. Han, H. Tritschler & L. Packer: α-Lipoic acid reduction by mammalian cells to the dithiol forms and release into the culture medium. Biochem. Pharmacol. 1994, 47, 1725-1730.
22. Hannemann, J. & K. Baumann: Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 1988, 51, 119-132.
23. Haramaki, N., D. Han, G. J. Handelman, H. J. Tritschlor & L. Packer: Cytosolic and mitochondrial systems for NADH and NADPH dependent reduction of alpha-lipoic acid. Free Rad. Biol. Med. 1997, 23, 535-542.
24. Heyman, S. N., K. Spokes, M. J. Egorin & F. Epstein: Glyci e reduces early renal parenhcymal uptake of cisplatin. Kidney Int. 1993, 43, 1226-1228.
25. Hidaka, S., M. Tsurupka, T. Funakoshi, H. Shimada, M. Kivozumi & S. Kolima: Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats. Renal Failure 1994, 16, 337-349.
26. Husain, K., C. Morris, C. Whitworth, G. L. Trammell, L. P. Rybak & S. M. Somani: 4-methylthiobenzoic acid protection against cisplatin nephrotoxicity: Antioxidant system. Fundam Appl. Toxicol. 1996, 32, 278-284.
27. Husain, K., C. Morris, C. Whitworth, G. L. Trammell, L. P. Rybak & S. M. Somani: Protection by ebselen against cisplatin-induced nephrotoxicity; antioxidant system. Mol. Cell Biochem. 1998, 178, 127-133.
28. Jones, M. M., M. A. Basinger & M. A. Holscher: Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res. 1991, 11, 449-454.
29. Kameyama, Y. & M. Gemba: Cisplatin-induced injury to calcium uptake by mitochondria in glutathione-depleted slices of rat kidney cortex. Jap. J. Pharmacol. 1991, 55, 174-176.
30. Litterst, C. L. & V. G. Schweitzer: Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: Possible role in nephrotoxicity. Res. Commun. Chem. Pathol. Pharmacol. 1988, 61, 35-48.
31. Maragon, K., S. Devaraj, O. Tirosh, L. Packer & I. Jialal: Comparison of the effect of lipoic acid and tocopherol supplementation on measures of oxidative stress. Free Rad. Biol. Med. 1999, 27, 1114-1121.
32. Markman, M., R. D'Acquito, N. Iannoti, H. Kois, T. Hakes, D. Bajorin, G. Bosl, B. Reichman, E. Casper & G. Magill: Phase I trial of high dose intravenous cisplatin with simultaneous intravenous sodium thiosulphate. J. Can. Res. Clin. Oncol. 1991, 117, 151-155.
33. McFariss, W & D. J. Reed: High performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Meth. Enzymol. 1987, 143, 101-109.
34. McGuiness, J. E., P. Proctor & H. Demopoulos: Ameloriation of cisplatinum nephrotoxicity by orgotein (Superoxide dismutase). Physiol. Chem. Phys. 1978, 10, 269-277.
35. Mistry, P., Y. Merazga, D. J. Spargo, P. A. Riley & D. C. H. McBrien: The effects of cisplatin on the concentration of protein thiols and glutatione in the rat kidney. Cancer Chemother. Pharmacol. 1991, 28, 277-282.
36. Misra, H. P. & I. Fridovich: The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide-dismutase. J. Biol. Chem. 1972, 247, 3170-3175.
37. Nagamatsu, M., K. K. Nickander, J. D. Schmelzer, A. Raya, D. A. Wittrock, H. Tritschler & P. A. Low: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995, 18, 1160-1167.
38. Nakano, S. & M. Gemba: Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jap. J. Pharmacol. 1988, 50, 87-92.
39. Ohkawa, H., N. Ohishi & K. Yagi: Assay for lipid peroxides in animals and tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
40. Packer, L., E. H. Wilt & H. J. Tritschler: Alpha-lipoic acid as a biological antioxident. Free Rad. Biol. Med. 1995, 19, 227-250.
41. Panigrahi, M., Y. Sadguna, B. R. Shirakumar, S. V. R. Kolluri, S. Roy, L. Packer & V. Ravindranath: Alpha-lipoic acid protects against perfusion injury following cerebral ischemia in rats. Brain Res. 1996, 717, 184-188.
42. Qazi, R., A. Y. Chang, R. F. Borch, T. Montine, P. Dedon, J. Loughner & J. M. Bennett: Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J. Natl. Can. Inst. 1988, 80, 1486-1488.
43. Ravi, R., S. M. Somani & L. P. Rybak: Mechanism of cisplatin ototoxicity: Antioxidant system. Pharmacology & Toxicology 1995, 76, 386-394.
44. Read, S. M. & D. H. Northcole: Minimization of variation in the response to different protein of the Coomassie blue G dye-binding assay for protein. Anal. Biochem. 1981, 116, 53-64.
45. Rybak, L. P., R. Ravi & S. M. Somani: Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fund. Appl. Toxicol. 1995, 26, 293-300.
46. Sandhya, P., S. Mohandass & P. Varalakshami: Role of DL alpha-lipoic acid in gentamicin induced nephrotoxicity. Mol. Cell. Biochem. 1995, 145, 11-17.
47. Sharma, R. P.: Interactions of cisplatin with cellular zinc and copper in liver and kidney tissues. Pharmacol. Res. Commun. 1985, 17, 197-206.
48. 2. Arch. Biochem. Biophys. 1981, 212, 411-416.
49. Somani, S. M., R. Ravi & L. P. Rybak: Diethyldithiocarbamate protection against cisplatin nephrotoxicity; Antioxidant System. Drug Chem. Toxicol. 1995, 18, 151-170.
50. Sugihara, K., S. Nakano, M. Koda, K. Tanaka, N. Fukuishi & M. Gemba: Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jap. J. Pharmacol. 1987, 43, 247-252.
51. Sumathi, R., G. Baskaran & P. Varalakshmi: Relationship between glutathione and DL alpha-lipoic acid against cadmium-induced hepatotoxicity. Jap. J. Med. Sci. Biol. 1996, 49, 39-18.
52. Tognella, S.: Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treat. Rev. 1990, 17, 139-142.
53. Uslu, R. & B. Bonavida: Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diammine dichloroplatinum. Cancer 1996, 77, 725-732.
54. Walker, E. M., Jr., M. A. Fazekas-May, K. W. Heard, S. Yee, D. Montague & M.M. Jones: Prevention of cisplatin-induced toxicity by selected dithiocarbamates. Ann. Clin. Lab. Sci. 1994, 24, 121-133.
55. Werner, P. & G. Cohen: Glutathione disulfide (GSSG) as a marker of oxidative injury to brain mitochondria. Ann. NY. Acad. Sci. 1993, 679, 364-369.
56. Wolfgang, G. H. I., M. A. Dominick, K. M. Walsh, J. D. Hoeschele & D. G. Pegg: Comparative nephrotoxicity of a novel platinum compound, cisplatin and carboplatin in male Wistar rats. Fundam. Appl. Toxicol 1994, 22, 73-79.
57. Younes, M. & C. P. Siegers: Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem. Biol. Interact. 1981, 34, 257-266.
58. Yuhas, J. M. & F. Culo: Selective inhibition of the nephrotoxicity of cisdichlorodiammineplatinum (II) by WR-2721 without altering its antitumor properties. Can. Treat. Rep. 1980, 64, 57-64.
59. Zhang, J. G. & W. E. Lindup: Role of mitochondria in cisplatin induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 1993, 45, 2215-2222.
60. Zunino, F., G. Pratesi, A. Micheloni, E. Cavalletti, F. Sala & O. Tofanetti: Protective effect of reduced glutahione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem. Biol Interact. 1989, 70, 89-101.